Quantitative detection of benzo[a]pyrene diolepoxide-DNA adducts by cryogenic laser induced fluorescence

Chemical Research in Toxicology

Volumn 16, Issue 1, 2003, Pages 74-80

  Luo, Wen ^a   Gurjuar, Rajan ^a   Ozbal, Can ^a   Taghizadeh, Koli ^a   Lafieur, Arthur ^a   Dasari, Ramachandra R ^a   Zarbl, Helmut ^b   Thilly, William G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYBENZO[A]PYRENE OXIDE; GENOMIC DNA; LIQUID NITROGEN; MUTAGENIC AGENT; TERBIUM; TERBIUM NITRATE; UNCLASSIFIED DRUG;

ARTICLE; CAMERA; CONTROLLED STUDY; CRYOTHERAPY; DNA ADDUCT; DNA REPAIR; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; LASER; LIGHT SCATTERING; LYMPHOBLASTOID CELL; QUANTITATIVE ANALYSIS;

BENZO(A)PYRENE; BENZOPYRENES; CARCINOGENS, ENVIRONMENTAL; DNA; DNA ADDUCTS; FREEZING; HUMANS; LASERS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; TUMOR CELLS, CULTURED;

EID: 12244298182     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0255065     Document Type: Article

References (50)

1. Hemminki, K., Koskinen, M., Rajaniemi, H., and Zhao, C. (2000) DNA adducts, mutations, and cancer 2000. Regal. Toxicol. Pharmacol. 32, 264-275.
2. Pavanello, S., Gabbani, G., Mastrangelo, G., Brugnone, F., Maccacaro, G., and Clonfero, E. (1999) Influence of GSTM1 genotypes on anti-BPDE-DNA adduct levels in mononuclear white blood cells of humans exposed to PAH. Int. Arch Occup. Environ. Health 72, 238-246.
3. Dickey, C., Santella, R. M., Hattis, D., Tang, D., Hsu, Y., Cooper, T., Young, T. L., and Perera, F. P. (1997) Variability in PAH-DNA adduct measurements in peripheral mononuclear cells: implications for quantitative cancer risk assessment. Risk Anal. 17, 649-656.
4. van Schooten, F. J., van Leeuwen, F. E., Hillebrand, M. J., de Rijke, M. E., Hart, A. A., van Veen, H. G., Oosterink, S., and Kriek, E. (1990) Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. J. Natl. Cancer Inst. 82, 927-933.
5. Penman, B. W., Crespi, C. L., Komives, E. A., Liber, H. L., and Thilly, W. G. (1983) Mutation of human lymphoblasts exposed to low concentrations of chemical mutagens for long periods of time. Mutat Res. 108, 417-436.
6. Danheiser, S. L., Liber, H. L., and Thilly, W. G. (1989) Long-term, low-dose benzo[a]pyrene-induced mutation in human lymphoblasts competent in xenobiotic metabolism. Mutat Res. 210, 143-147.
7. Chen, J., and Thilly, W. G. (1996) Mutational spectra vary with exposure conditions: benzo[a]pyrene in human cells. Mutat Res. 357, 209-217.
8. Jankowiak, R., and Small, G. J. (1991) Fluorescence line narrowing: a high-resolution window on DNA and protein damage from chemical carcinogens. Chem. Res. Toxicol. 4, 256-269.
9. Jankowiak, R., Cooper, R. S., Zamzow, D., Small, G. J., Doskocil, G., and Jeffrey, A. M. (1988) Fluorescence line narrowing-nonphotochemical hole burning spectrometry: femtomole detection and high selectivity for intact DNA-PAH adducts. Chem Res Toxicol. 1, 60-68.
10. Roberts, K. P., Lin, C. H., Singhal, M., Casale, G. P., Small, G. J., and Jankowiak, R. (2000) On-line identification of depurinating DNA adducts in human urine by capillary electrophoresism - fluorescence line narrowing spectroscopy. Electrophoresis 21, 799-806.
11. Devanesan, P., Ariese, F., Jankowiak, R., Small, G. J., Rogan, E. G., and Cavalieri, E. L. (1999) A novel method for the isolation and identification of stable DNA adducts formed by Dibenzo[a,1]pyrene and Dibenzo[a,1]pyrene 11, 12-dihydrodiol 13,14-epoxides in vitro. Chem. Res. Toxicol. 12, 796-801.
12. 32P-postlabeling and fluorescence studies. Chem. Res. Toxicol. 11, 674-685.
13. Jankowiak, R., Zamzow, D., Stack, D. E., Todorovic, R., Cavalieri, E. L., and Small, G. J. (1998) Spectral characterization of fluorescently labeled catechol estrogen 3,4-quinone-derived N7 guanine adducts and their identification in rat mammary gland tissue. Chem. Res. Toxicol. 11, 1339-1345.
14. Zamzow, D., Lin, C. H., Small, G. J., and Jankowiak, R. (1997) Application of capillary electrophoresis-fluorescence line-narrowing spectroscopy for on-line spectral characterization of closely related analytes. J. Chromatogr. A. 781, 73-80.
15. 2-dG in duplex oligonucleotides using polyacrylamide gel electrophoresis and low - temperature fluorescence spectroscopy. Biophys. Chem. 56, 281-296.
16. Rogan, E. G., Devanesan, P. D., RamaKrishna, N. V., Higginbotham, S., Padmavathi, N. S., Chapman, K., Cavalieri, E. L., Jeong, H., Jankowiak, R., and Small, G. J. (1993) Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6, 356-363.
17. Devanesan, P. D., RamaKrishna, N. V., Padmavathi, N. S., Higginbotham, S., Rogan, E. G., Cavalieri, E. L., Marsch, G. A., Jankowiak, R., and Small, G. J. (1993) Identification and quantitation of 7,12-dimethylbenz[a]anthracene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6, 364-371.
18. Zhao, R., Liu, T. M., Kim, S. K., MacLeod, M. C., and Geacintov, N. E. (1992) Identification and quantitative detection of isomeric benzo[a]pyrene diolepoxide- -DNA adducts by low-temperature conventional fluorescence methods. Carcinogenesis 13, 1817-1824.
19. Jankowiak, R., Lu, P. Q., Small, G. J., and Geacintov, N. E. (1990) Laser spectroscopic studies of DNA adduct structure types from enantiomeric diol epoxides of benzo[a]pyrene. Chem Res Toxicol. 3, 39-46.
20. Heisig, V., Jeffrey, A. M., McGlade, M. J., and Small, G. J. (1984) Fluorescence-line-narrowed spectra of polycyclic aromatic carcinogen-DNA adducts. Science 223, 289-291.
21. Sanders, M. J., Cooper, R. S., Small, G. J., Heisig, V., and Jeffrey, A. M. (1985) Identification of polycyclic aromatic hydrocarbon metabolites in mixtures using fluorescence line narrowing spectrometry. Anal. Chem. 57, 1148-1152.
22. Sanders, M. J., Cooper, R. S., Jankowiak, R., Small, G. J., Heisig, V., and Jeffrey, A. M. (1986) Identification of polycyclic aromatic hydrocarbon metabolites and DNA adducts in mixtures using fluorescence line narrowing spectrometry. Anal. Chem. 58, 816-820.
23. Jankowiak, R., Cooper, R. S., Zamzow, D., Small, G. J., Doskocil, G., and Jeffrey, A. M. (1988) Enhancement of sensitivity of fluorescence line narrowing spectrometry for detection of carcinogen-DNA adducts. IARC Sci. Publ. 89, 372-377.
24. Skopek, T. R., Liber, H. L., Penman, B. W., and Thilly, W. G. (1978) Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay. Biochem. Biophys. Res. Commun. 84, 411-416.
25. Crespi, C. L., Liber, H. L., Behymer, T. D., Hites, R. A., and Thilly, W. G. (1985) A human cell line sensitive to mutation by particleborne chemicals. Mutat. Res. 157, 71-75.
26. Freedman, H. J., Parker, N. B., Marinello, A. J., Gurtoo, H. L., and Minowada, J. (1979) Induction, inhibition, and biological properties of aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788. Cancer Res. 39, 4612-4619.
27. Freedman, H. J., Gurtoo, H. L., Minowada, J., Paigen, B., and Vaught, J. B. (1979) Aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788, cultured in the absence of mitogen. Cancer Res. 39, 4605-4611.
28. Crespi, C. L., and Thilly, W. G. (1984) Assay for gene mutation in a human lymphoblast line, AHH-1, competent for xenobiotic metabolism. Mutat. Res. 128, 221-230.
29. Day, B. W., Doxtader, M. M., Rich, R. H., Skipper, P. L., Singh, K., Dasari, R. R., and Tannenbaum, S. R. (1992) Human serum albumin-benzo[a]pyrene anti-diol epoxide adduct structure elucidation by fluorescence line narrowing spectroscopy. Chem. Res. Toxicol. 5, 71-76.
30. Weston, A. (1993) Physical methods for the detection of carcinogen-DNA adducts in humans. Mutat. Res. 288, 19-29.
31. Kriek, E., Rojas, M., Alexandrov, K., and Bartsch, H. (1998) Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat. Res. 400, 215-231.
32. Poirier, M. C., Santella, R. M., and Weston, A. (2000) Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21, 353-359.
33. Rojas, M., Cascorbi, I., Alexandrov, K., Kriek, E., Auburtin, G., Mayer, L., Kopp-Schneider, A., Roots, I., and Bartsch, H. (2000) Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis 21, 35-41.
34. Pavanello, S., Favretto, D., Brugnone, F., Mastrangelo, G., Dal Pra, G., and Clonfero, E. (1999) HPLC/fluorescence determination of anti-BPDE-DNA adducts in mononuclear white blood cells from PAH-exposed humans. Carcinogenesis 20, 431-435.
35. Poirier, M. C. (1993) Antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA: applications for detection of xenobiotics in biological samples. Mutat. Res. 288, 31-38.
36. Poirier, M. C. (1994) Human exposure monitoring, dosimetry, and cancer risk assessment: the use of antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA. Drug Metab. Rev. 26, 87-109.
37. Randerath, K., and Randerath, E. (1994) postlabeling methods for DNA adduct detection: overview and critical evaluation. Drug Metab. Rev. 26, 67-85.
38. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis 9, 1687-1693.
39. 32P-postlabeling analysis of non-radioactive aromatic carcinogen - DNA adducts. Carcinogenesis 3, 1081-1092.
40. Casale, G. P., Singhal, M., Bhattacharya, S., RamaNathan, R., Roberts, K. P., Barbacci, D. C., Zhao, J., Jankowiak, R., Gross, M. L., Cavalieri, E. L., Small, G. J., Rennard, S. I., Mumford, J. L., and Shen, M. (2001) Detection and quantification of depurinated benzo[a]pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke. Chem. Res. Toxicol. 14, 192-201.
41. Gangl, E. T., Turesky, R. J., and Vouros, P. (2001) Detection of in vivo formed DNA adducts at the part-per-billion level by capillary liquid chromatography/microelectrospray mass spectrometry. Anal. Chem. 73, 2397-2404.
42. Soglia, J. R., Turesky, R. J., Paehler, A., and Vouros, P. (2001) Quantification of the heterocyclic aromatic amine DNA adduct N-(deoxyguanosin-8-yl)-2-amino-3-methylimidazo[4,5-f] quinoline in livers of rats using capillary liquid chromatography/microelectrospray mass spectrometry: a dose-response study. Anal. Chem. 73, 2819-2827.
43. Marzilli, L. A., Koertje, C., and Vouros, P. (2001) Capillary electrophoresis-mass spectrometric analysis of DNA adducts. Methods Mol. Biol. 163, 395-406.
44. Chen, J., MacLeod, M. C., Zhao, R., and Geacintov, N. E. (1993) Fluorescence HPLC methods for detecting benzo[a]pyrene-7,8-dihydrodiol 9,10-oxide-deoxyadenosine adducts in enzyme-digests of modified DNA: improved sensitivity. Carcinogenesis 14, 1049-1051.
45. Alexandrov, K., Rojas, M., Geneste, O., Castegnaro, M., Camus, A. M., Petruzzelli, S., Giuntini, C., and Bartsch, H. (1992) An improved fluorometric assay for dosimetry ofbenzo[a]pyrene diolepoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res. 52, 6248-6253.
46. Roche, C. J., Zinger, D., Geacintov, N. E., and Harvey, R. G. (1985) Enhancement of stability of 7 beta,8 alpha-dihydroxy-9 alpha epoxybenzo[a]pyrene by complex formation with serum albumin. Cancer Biochem. Biophys. 8, 35-40.
47. Brauze, D., Mikstacka, R., and Baer-Dubowska, W. (1991) Formation and persistence of benzo[a]pyrene-DNA adducts in different tissues of C57BL/10 and DBA/2 mice. Carcinogenesis 12, 1607-1611.
48. Venkatachalam, S., Denissenko, M., and Wani, A. A. (1995) DNA repair in human cells: quantitative assessment of bulky anti-BPDE-DNA adducts by non-competitive immunoassays. Carcinogenesis 16, 2029-2036.
49. Nakayama, J., Yuspa, S. H., and Poirier, M. C. (1984) Benzo[a]pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis. Cancer Res. 44, 4087-4095.
50. 32P-postlabeling analysis of the formation and persistence of DNA adducts in mammary glands of parous and nulliparous mice treated with benzo[a]pyrene. Carcinogenesis 13, 2009-2015.